139 related articles for article (PubMed ID: 27462186)
1. Topoisomerase IIβ mediates the resistance of glioblastoma stem cells to replication stress-inducing drugs.
Kenig S; Faoro V; Bourkoula E; Podergajs N; Ius T; Vindigni M; Skrap M; Lah T; Cesselli D; Storici P; Vindigni A
Cancer Cell Int; 2016; 16():58. PubMed ID: 27462186
[TBL] [Abstract][Full Text] [Related]
2. NMDA Receptor Signaling Mediates cFos Expression via Top2β-Induced DSBs in Glioblastoma Cells.
Lutz H; Nguyen TA; Joswig J; Rau K; Laube B
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30841565
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitivity of Patient-Derived Glioma Stem Cell 3-Dimensional Cultures to Photon, Proton, and Carbon Irradiation.
Chiblak S; Tang Z; Campos B; Gal Z; Unterberg A; Debus J; Herold-Mende C; Abdollahi A
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):112-119. PubMed ID: 26254681
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane.
Lyu YL; Kerrigan JE; Lin CP; Azarova AM; Tsai YC; Ban Y; Liu LF
Cancer Res; 2007 Sep; 67(18):8839-46. PubMed ID: 17875725
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
[TBL] [Abstract][Full Text] [Related]
6. G-quadruplex ligand-induced DNA damage response coupled with telomere dysfunction and replication stress in glioma stem cells.
Hasegawa D; Okabe S; Okamoto K; Nakano I; Shin-ya K; Seimiya H
Biochem Biophys Res Commun; 2016 Feb; 471(1):75-81. PubMed ID: 26845351
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic reticulum stress-inducing drugs sensitize glioma cells to temozolomide through downregulation of MGMT, MPG, and Rad51.
Xipell E; Aragón T; Martínez-Velez N; Vera B; Idoate MA; Martínez-Irujo JJ; Garzón AG; Gonzalez-Huarriz M; Acanda AM; Jones C; Lang FF; Fueyo J; Gomez-Manzano C; Alonso MM
Neuro Oncol; 2016 Aug; 18(8):1109-19. PubMed ID: 26951384
[TBL] [Abstract][Full Text] [Related]
8. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
[TBL] [Abstract][Full Text] [Related]
9. Sulindac induces differentiation of glioblastoma stem cells making them more sensitive to oxidative stress.
Allani SK; Weissbach H; Lopez Toledano MA
Neoplasma; 2018 Mar; 65(3):376-388. PubMed ID: 29788733
[TBL] [Abstract][Full Text] [Related]
10. Topoisomerase IIβ Selectively Regulates Motor Neuron Identity and Peripheral Connectivity through Hox/Pbx-Dependent Transcriptional Programs.
Edmond M; Hanley O; Philippidou P
eNeuro; 2017; 4(6):. PubMed ID: 29379870
[TBL] [Abstract][Full Text] [Related]
11. β-elemene inhibits stemness, promotes differentiation and impairs chemoresistance to temozolomide in glioblastoma stem-like cells.
Zhu TZ; Li XM; Luo LH; Song ZQ; Gao X; Li ZQ; Su JY; Liang GB
Int J Oncol; 2014 Aug; 45(2):699-709. PubMed ID: 24841897
[TBL] [Abstract][Full Text] [Related]
12. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and characterization of the human topoisomerase IIalpha and IIbeta genes: evidence for isoform evolution through gene duplication.
Sng JH; Heaton VJ; Bell M; Maini P; Austin CA; Fisher LM
Biochim Biophys Acta; 1999 Mar; 1444(3):395-406. PubMed ID: 10095062
[TBL] [Abstract][Full Text] [Related]
14. Role of Topoisomerase IIβ in DNA Damage Response following IR and Etoposide.
Sunter NJ; Cowell IG; Willmore E; Watters GP; Austin CA
J Nucleic Acids; 2010 Aug; 2010():. PubMed ID: 20847952
[TBL] [Abstract][Full Text] [Related]
15. Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells.
Song WS; Yang YP; Huang CS; Lu KH; Liu WH; Wu WW; Lee YY; Lo WL; Lee SD; Chen YW; Huang PI; Chen MT
J Chin Med Assoc; 2016 Oct; 79(10):538-45. PubMed ID: 27530866
[TBL] [Abstract][Full Text] [Related]
16. Replication Stress: An Achilles' Heel of Glioma Cancer Stem-like Cells.
Morgan MA; Canman CE
Cancer Res; 2018 Dec; 78(24):6713-6716. PubMed ID: 30498082
[TBL] [Abstract][Full Text] [Related]
17. Functional and Molecular Heterogeneity in Glioma Stem Cells Derived from Multiregional Sampling.
Brynjulvsen M; Solli E; Walewska M; Zucknick M; Djirackor L; Langmoen IA; Mughal AA; Skaga E; Vik-Mo EO; Sandberg CJ
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136371
[TBL] [Abstract][Full Text] [Related]
18. Potential Therapeutic Effects of the Neural Stem Cell-Targeting Antibody Nilo1 in Patient-Derived Glioblastoma Stem Cells.
Rackov G; Iegiani G; Uribe D; Quezada C; Belda-Iniesta C; Escobedo-Lucea C; Silva A; Puig P; González-Rumayor V; Ayuso-Sacido Á
Front Oncol; 2020; 10():1665. PubMed ID: 32974206
[TBL] [Abstract][Full Text] [Related]
19. BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.
Im CN; Yun HH; Song B; Youn DY; Cui MN; Kim HS; Park GS; Lee JH
Oncotarget; 2016 Jun; 7(23):35056-70. PubMed ID: 27145367
[TBL] [Abstract][Full Text] [Related]
20. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
